Clinical Management of Antirheumatic Drug Exposure During Therapeutic Plasma Exchange

Conrad N, Misra S, Verbakel JY et al (2023) Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet 401(10391):1878–1890. https://doi.org/10.1016/S0140-6736(23)00457-9

Article  PubMed  Google Scholar 

Bergman D, Sundquist K, Segelmark M et al (2026) Incidence and prevalence of autoimmune disease in the Swedish National Patient Register. Eur J Epidemiol Published online Febr 21. https://doi.org/10.1007/s10654-026-01369-3

Mu S, Wang W, Liu Q et al (2024) Autoimmune disease: a view of epigenetics and therapeutic targeting. Front Immunol 15:1482728. https://doi.org/10.3389/fimmu.2024.1482728

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miller FW (2023) The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol 80:102266. https://doi.org/10.1016/j.coi.2022.102266

Article  CAS  PubMed  Google Scholar 

Peedin AR, Karp JK (2019) Revisiting the role of therapeutic plasma exchange in the management of catastrophic antiphospholipid syndrome. J Thromb Haemost 17(7):1179–1180. https://doi.org/10.1111/jth.14400

Article  PubMed  Google Scholar 

Crow MK (2023) Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheum Dis 82(8):999–1014. https://doi.org/10.1136/ard-2022-223741

Article  CAS  PubMed  Google Scholar 

Cervantes CE, Bloch EM, Sperati CJ (2023) Therapeutic plasma exchange: core curriculum 2023. Am J Kidney Dis 81(4):475–492. https://doi.org/10.1053/j.ajkd.2022.10.017

Article  PubMed  Google Scholar 

Robinson G, Pineda-Torra I, Ciurtin C, Jury EC (2022) Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies. J Clin Invest 132(2):e148552. https://doi.org/10.1172/JCI148552

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zanatta E, Cozzi M, Marson P, Cozzi F (2019) The role of plasma exchange in the management of autoimmune disorders. Br J Haematol 186(2):207–219. https://doi.org/10.1111/bjh.15903

Article  PubMed  Google Scholar 

Ibrahim RB, Balogun RA (2013) Medications and therapeutic apheresis procedures: are we doing our best? J Clin Apher 28(1):73–77. https://doi.org/10.1002/jca.21261

Article  PubMed  Google Scholar 

Balaban U, Kara E, Pinar A, Ozcebe OI, Demirkan K, Unal S (2024) Antimicrobial management in patients undergoing therapeutic plasma exchange: a cross-sectional nationwide survey. J Investig Med 72(8):920–929. https://doi.org/10.1177/10815589241270414

Article  PubMed  Google Scholar 

Donnelly M, Fang L, Madabushi R et al (2025) Narrow therapeutic index drugs: FDA experience, views, and operations. Clin Pharmacol Ther 117(1):116–129. https://doi.org/10.1002/cpt.3460

Article  PubMed  Google Scholar 

Habet S (2021) Narrow therapeutic index drugs: clinical pharmacology perspective. J Pharm Pharmacol 73(10):1285–1291. https://doi.org/10.1093/jpp/rgab102

Article  PubMed  Google Scholar 

Association, HPPC of CP, Association, CPB of CM, Drugs WG of CEC on CAM of NTI (2025) Chinese expert consensus on the clinical application management of narrow therapeutic index drugs. Zhongguo Yi Yuan Yao Xue Za Zhi 45(17):1933–1946. https://doi.org/10.13286/j.1001-5213.2025.17.01

Article  Google Scholar 

Rosenberg J, Benowitz NL, Pond S (1981) Pharmacokinetics of drug overdose. Clin Pharmacokinet 6(3):161–192. https://doi.org/10.2165/00003088-198106030-00001

Article  CAS  PubMed  Google Scholar 

Stigelman WH, Henry DH, Talbert RL, Townsend RJ (1984) Removal of prednisone and prednisolone by plasma exchange. Clin Pharm 3(4):402–407

PubMed  Google Scholar 

Kintzel PE, Eastlund T, Calis KA (2003) Extracorporeal removal of antimicrobials during plasmapheresis. J Clin Apher 18(4):194–205. https://doi.org/10.1002/jca.10074

Article  PubMed  Google Scholar 

Chan GL, Hodge EE (1991) Effect of plasmapheresis on cyclosporine pharmacokinetics. DICP 25(2):211. https://doi.org/10.1177/106002809102500220

Article  CAS  PubMed  Google Scholar 

Balogun RA, Sahadevan M, Sevigny J, Kaplan AA (2001) Impact of therapeutic plasma exchange on cyclosporine kinetics during membrane-based lipid apheresis. Am J Kidney Dis 37(6):1286–1289. https://doi.org/10.1053/ajkd.2001.24536

Article  CAS  PubMed  Google Scholar 

Leitner GC, Hiesmayr M, Hoecker P, Jilma B (2003) Therapeutic approaches in the management of oral cyclosporine A intoxication. Transplantation 75(10):1764–1765. https://doi.org/10.1097/01.TP.0000063935.20334.4B

Article  PubMed  Google Scholar 

Kwon SU, Lim SH, Rhee I et al (2006) Successful whole blood exchange by apheresis in a patient with acute cyclosporine intoxication without long-term sequelae. J Heart Lung Transplant 25(4):483–485. https://doi.org/10.1016/j.healun.2005.11.440

Article  PubMed  Google Scholar 

Moorman MT, Epstein RB, Smith JW, O’Neal C, Holter JL (2011) Management of cyclosporine overdose in a hematopoietic stem cell transplant patient with sequential plasma exchange and red blood cell exchange. J Clin Apher 26(3):156–158. https://doi.org/10.1002/jca.20277

Article  PubMed  Google Scholar 

Varl J, Ponikvar R, Drinovec J, Kveder R, Zemva Z (1990) Effect of plasmapheresis on blood and plasma cyclosporin levels. Prog Clin Biol Res 337:363–365

CAS  PubMed  Google Scholar 

Przepiorka D, Suzuki J, Ippoliti C, Hester JP, Fritsche HA (1994) Blood tacrolimus concentration unchanged by plasmapheresis. Am J Hosp Pharm 51(13):1708

CAS  PubMed  Google Scholar 

Hale GA, Reece DE, Munn RK, Kniska AB, Phillips GL (2000) Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis. Bone Marrow Transpl 25(4):449–451. https://doi.org/10.1038/sj.bmt.1702174

Article  CAS  Google Scholar 

Kawauchi S, Wada K, Oita A (2019) Changes in blood concentration of mycophenolic acid and FK506 in a heart-transplant patient treated with plasmapheresis. Int J Clin Pharmacol Ther 57(1):32–36. https://doi.org/10.5414/CP203278

Article  PubMed  Google Scholar 

Goto Y, Nakajima T, Suzuki T et al (2021) Evaluation of tacrolimus and mycophenolic acid removal by simultaneous continuous hemodiafiltration and plasma exchange in a lung transplant patient. J Clin Pharm Ther 46(2):515–518. https://doi.org/10.1111/jcpt.13286

Article  CAS  PubMed  Google Scholar 

Piyasiridej S, Townamchai N, Udomkarnjananun S et al (2019) Plasmapheresis reduces mycophenolic acid concentration: a study of full AUC0-12 in kidney transplant recipients. J Clin Med 8(12):2084. https://doi.org/10.3390/jcm8122084

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maldonado AQ, Davies NM, Crow SA, Little C, Ojogho ON, Weeks DL (2011) Effects of plasmapheresis on mycophenolic acid concentrations. Transplantation 91(1):e3–4. https://doi.org/10.1097/TP.0b013e3181fc0a35

Article  CAS  PubMed  Google Scholar 

Thierry FX, Vernier I, Dueymes JM et al (1989) Acute renal failure after high-dose methotrexate therapy. Role of hemodialysis and plasma exchange in methotrexate removal. Nephron 51(3):416–417. https://doi.org/10.1159/000185335

Article  CAS  PubMed  Google Scholar 

Kepka L, De Lassence A, Ribrag V et al (1998) Successful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure. Leuk Lymphoma 29(1–2):205–209. https://doi.org/10.3109/10428199809058397

Article  CAS  PubMed  Google Scholar 

Cecyn KZ, Lee J, Oguro T, Petrilli AS, Bordin JO (2003) Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency. Am J Hematol 72(3):209–211. https://doi.org/10.1002/ajh.10271

Comments (0)

No login
gif